FDA approves Novavax's vaccine - Search News

Novavax, Covid-19 and FDA

FDA Approves Updated Novavax COVID Vaccine Week After Approving Moderna And Pfizer’s Shots

The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

FDA approves Novavax's updated COVID-19 vaccine

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that are now circulating.

YAHOO!Finance · 4d

FDA Approves Novavax's Updated COVID Vaccine Targeting Currently Circulating Variants

Friday, the FDA granted Emergency Use Authorization to Novavax Inc.’s (NASDAQ:NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) for active immunization to prevent COVID-19 in individuals aged 12 and older.

YAHOO!News · 1d

FDA approved new COVID-19 vaccines. Here's what to know and where to get them

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against serious COVID-19 impacts.

CNBC on MSN · 7d

FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout

The decision comes only a week after it approved a new round of messenger RNA shots from Pfizer and Moderna, which both target an offshoot of JN.1 called KP.2.

The Hill on MSN · 7d

FDA approves updated Novavax COVID vaccine amid summer surge

The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID-19 vaccine amid the summer surge of infections. The new version of the vaccine “more closely targets” variants circulating nationwide,

Pharmaceutical Technology on M… · 4d

Novavax wins FDA emergency approval for updated Covid-19 vaccine

The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the past two weeks.

Novavax Catches Up to Competitors With FDA Approval for Updated COVID-19 Boosters

Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a recombinant version of the virus’ spike protein to elicit protection.

dermatologyadvisor · 2d

FDA Approves Updated COVID-19 Vaccines for Fall

This year’s approval for the updated mRNA vaccines comes much sooner than happened in 2023, when fall vaccines were authorized on Sept. 11. The latest shots from Moderna and Pfizer will now target a variant of the Omicron strain of the virus called KP.2, the FDA said in a statement.

americanbazaaronline.com · 2d

Novavax receives FDA Emergency Use Authorization for updated Covid-19 vaccine

The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across thousands of U.S. locations starting next week

WTOP News · 4d

New Novavax COVID-19 vaccine now headed to pharmacies

Gaithersburg, Maryland-based Novavax received emergency use authorization for its updated COVID-19 vaccine on Aug. 30 and said the vaccine is ready to ship.

FDA approves new COVID-19 vaccine to ‘better protect against’ new variants

The Food and Drug Administration granted emergency use authorization Friday for an updated version of the Novavax COVID-19 ...

Zacks.com on MSN2d

Biotech Stock Roundup: NVAX Vaccine Approval, ALNY, ATHA Stock Dive on Updates & More

It was a busy week for the biotech sector, with a lot of important data readouts and regulatory updates. Among these, Novavax ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results